Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway
Open Access
- 1 September 2000
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 275 (37), 28371-28379
- https://doi.org/10.1074/jbc.m004554200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Role of NF-κB in p53-mediated programmed cell deathNature, 2000
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFκBFEBS Letters, 1998
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBαImmunity, 1996
- Müllerian inhibiting substance in reproduction and cancerMolecular Reproduction and Development, 1992
- Effects of TGF? on Normal and Malignant Mammary EpitheliumAnnals of the New York Academy of Sciences, 1990
- The Ontogeny of Mullerian Inhibiting Substance in Granulosa Cells of the Bovine Ovarian FollicleBiology of Reproduction, 1986
- Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assayGynecologic Oncology, 1985